Management of Alcohol-Related Liver Disease
The harmful use of alcohol has been estimated to cause approximately 3.3 million deaths every year. Most importantly, this corresponds to nearly 6% of all deaths globally. Therefore, the effective treatment and Management of Alcohol-Related Liver Disease is a pertinent public health issue. In conclusion, the following EASL Clinical Practice Guideline reviews and provides the latest data on the treatment and Management of Alcohol-Related Liver Disease and updates recommendations for clinical management.
More on the Management of Alcohol-Related Liver Disease
According to the World Health Organization’s (WHO) 2014 report on noncommunicable diseases, harmful use of alcohol causes approximately 3.3 million deaths every year. Above all, this corresponds to 5.9% of all the worldwide deaths. Furthermore, 139 million disability-adjusted life years, or 5.1% of the global burden of disease and injury, were attributable to alcohol consumption. The proportion of global deaths attributable to alcohol differs based on gender. 7.6% of deaths among males and 4.0% of deaths among females are attributable to alcohol. Most importantly, alcohol-related morbidity and mortality has a wide geographical variation. The highest alcohol-attributable fractions are reported in the WHO European Region.
Within each country there is an excellent correlation between the level of alcohol consumption and the prevalence of alcohol-related harm. In fact, mean alcohol consumption in the World is 6.2 litres of pure alcohol per person per year. The consumption in Europe is 10.9 litres/year. Most importantly, according to data from the Organisation for Economic Co-operation and Development report 2017, alcohol consumption in the OECD countries, averaged nine liters of pure alcohol per person per year.
Download the EASL Guideline for Management of Alcohol-Related Liver Disease as PDF or as PPT Slide Deck from the right of your screen.